Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes
Cancer cells tend to develop resistance to chemotherapy and enhance aggressiveness. A counterintuitive approach is to tame aggressiveness by an agent that acts opposite to chemotherapeutic agents. Based on this strategy, induced tumor-suppressing cells (iTSCs) have been generated from tumor cells an...
Main Authors: | Kexin Li, Xun Sun, Hudie Li, Hailan Ma, Meng Zhou, Kazumasa Minami, Keisuke Tamari, Kazuhiko Ogawa, Pankita H. Pandya, M. Reza Saadatzadeh, Melissa A. Kacena, Karen E. Pollok, Bai-Yan Li, Hiroki Yokota |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2023-07-01
|
Series: | Genes and Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352304222002288 |
Similar Items
-
Osteosarcoma-enriched transcripts paradoxically generate osteosarcoma-suppressing extracellular proteins
by: Kexin Li, et al.
Published: (2023-03-01) -
Radiation Dose Escalation Is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma
by: Wataru Takenaka, et al.
Published: (2020-06-01) -
3D-printing magnesium–polycaprolactone loaded with melatonin inhibits the development of osteosarcoma by regulating cell-in-cell structures
by: Weilin Zhang, et al.
Published: (2021-09-01) -
Exome Sequencing Diagnoses X-Linked Moesin-Associated Immunodeficiency in a Primary Immunodeficiency Case
by: Gabrielle Bradshaw, et al.
Published: (2018-03-01) -
Primary osteosarcoma of the breast
by: Hung-An Huang, et al.
Published: (2021-01-01)